These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 3301947)

  • 1. Enhancement of monocyte chemotactic activity in the sera of psoriatic patients after heat treatment.
    Isoda M; Hidaka K
    J Dermatol; 1987 Feb; 14(1):29-32. PubMed ID: 3301947
    [No Abstract]   [Full Text] [Related]  

  • 2. Polymorphonuclear leukocyte chemotaxis in psoriasis: enhancement by self-activated serum.
    Kawohl G; Szperalski B; Schröder JM; Christophers E
    Br J Dermatol; 1980 Nov; 103(5):527-33. PubMed ID: 7437318
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monocyte and neutrophil chemotaxis in psoriasis. Relation to the clinical status and the type of psoriasis.
    Ternowitz T
    J Am Acad Dermatol; 1986 Dec; 15(6):1191-9. PubMed ID: 3027138
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The enhanced monocyte and neutrophil chemotaxis in psoriasis is normalized after treatment with psoralens plus ultraviolet A and anthralin.
    Ternowitz T
    J Am Acad Dermatol; 1987 Jun; 16(6):1169-75. PubMed ID: 3597858
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reduction of chemotactic activities in psoriatic lesions by hyperthermia treatments.
    Isoda M; Oosaki M; Yasumoto S; Urabe H
    J Dermatol; 1984 Aug; 11(4):386-90. PubMed ID: 6392385
    [No Abstract]   [Full Text] [Related]  

  • 6. Neutrophil and monocyte chemotaxis in methotrexate-treated psoriasis patients.
    Ternowitz T; Herlin T
    Acta Derm Venereol Suppl (Stockh); 1985; 120():23-6. PubMed ID: 3869414
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Psoriasis and leukocyte chemotaxis.
    Tagami H; Iwatsuki K; Takematsu H
    J Invest Dermatol; 1987 Mar; 88(3 Suppl):18s-23s. PubMed ID: 3493302
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Monocyte and neutrophil chemotactic activity of normal and diluted human serum and plasma.
    Jungi TW
    Int Arch Allergy Appl Immunol; 1977; 53(1):18-28. PubMed ID: 838512
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The adherence to human endothelium and plastic of neutrophils from psoriatic patients, and the effects of psoriatic patients' sera on normal neutrophils.
    Majewski S; Jabłonska S; Langner A; Pawinska M; Szmurło A
    Br J Dermatol; 1985 Jun; 112(6):655-62. PubMed ID: 4038367
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of Legionella pneumophila sonicate on human neutrophil granulocyte and monocyte chemotaxis.
    Rechnitzer C; Kharazmi A; Nielsen H
    Eur J Clin Invest; 1986 Oct; 16(5):368-75. PubMed ID: 3100304
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Chemotaxis activity of neutrophils and monocytes in patients with psoriasis vulgaris in relation to PUVA therapy].
    Poljacki M; Jovanović M; Budakov M; Duran V; Subotić M
    Med Pregl; 1995; 48(7-8):217-21. PubMed ID: 8524193
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Neutrophil granulocyte chemotaxis and psoriasis].
    Christophers E; Schröder JM
    Hautarzt; 1981 Nov; 32(11):558-63. PubMed ID: 6458581
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhanced monocyte and neutrophil cytotoxicity and normal cyclic nucleotide levels in severe psoriasis.
    Herlin T; Kragballe K
    Br J Dermatol; 1981 Oct; 105(4):405-13. PubMed ID: 6271161
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Etretinate therapy reduces polymorphonuclear leukocyte chemotaxis--enhancing properties of psoriatic serum.
    Ellis CN; Kang S; Grekin RC; Voorhees JJ; Silva J
    J Am Acad Dermatol; 1985 Sep; 13(3):437-43. PubMed ID: 4056118
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neutrophil leukocyte migration in psoriasis vulgaris.
    Breathnach SM; Carrington P; Black MM
    J Invest Dermatol; 1981 Apr; 76(4):271-4. PubMed ID: 7205028
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A role for humoral factors in psoriasis.
    Krueger GG; Chambers DA; Stubbs JD; Jederberg WW; Torres AR
    J Lab Clin Med; 1982 Feb; 99(2):275-87. PubMed ID: 7061921
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biologic therapy improves psoriasis by decreasing the activity of monocytes and neutrophils.
    Yamanaka K; Umezawa Y; Yamagiwa A; Saeki H; Kondo M; Gabazza EC; Nakagawa H; Mizutani H
    J Dermatol; 2014 Aug; 41(8):679-85. PubMed ID: 25099154
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased monocyte chemotaxis towards leukotriene B4 and platelet activating factor in patients with inflammatory dermatoses.
    Czarnetzki B
    Clin Exp Immunol; 1983 Nov; 54(2):486-92. PubMed ID: 6317241
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polymorphonuclear leukocytes: possible mechanism of accumulation in psoriasis.
    Lazarus GS; Yost FJ; Thomas CA
    Science; 1977 Dec; 198(4322):1162-3. PubMed ID: 929193
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of Efalizumab on neutrophil and monocyte functions in patients with psoriasis.
    Capsoni F; Ongari AM; Frigerio E; Taglioni M; Altomare GF
    Int J Immunopathol Pharmacol; 2008; 21(2):437-45. PubMed ID: 18547491
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.